{
  "meta": {
    "title": "37_Hemolytic_Anemia",
    "url": "https://brainandscalpel.vercel.app/37-hemolytic-anemia-358caf1f.html",
    "scrapedAt": "2025-11-30T06:57:16.784Z"
  },
  "questions": [
    {
      "id": 76333,
      "choices": [
        {
          "id": 257450,
          "text": "Low LDH levels"
        },
        {
          "id": 257451,
          "text": "Increased reticulocyte count"
        },
        {
          "id": 257452,
          "text": "Splenomegaly"
        },
        {
          "id": 257453,
          "text": "Increased bilirubin"
        }
      ],
      "text": "Not a feature of haemolytic anaemia ?",
      "unique_key": "Q5171434",
      "question_audio": null,
      "question_video": null,
      "map_id": 34558426,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Low LDH levels. Correct Response Explanation: Hemolytic anemia is characterized by high lactate dehydrogenase (LDH) levels, not low LDH levels. LDH is released from damaged red blood cells (RBCs) into the bloodstream during hemolysis, leading to elevated LDH levels. A low LDH level would not be consistent with hemolytic anemia and helps exclude this condition. Incorrect Response Explanations: (B) Increased reticulocyte count: In hemolytic anemia, there is increased destruction of RBCs, prompting the bone marrow to compensate by producing more red blood cells. This leads to a high reticulocyte count, which reflects an active marrow response. This is a hallmark feature of hemolytic anemia. (C) Splenomegaly: The spleen plays a central role in the destruction of abnormal or damaged RBCs. Chronic hemolysis can lead to splenomegaly due to increased workload. It is commonly observed in various types of hemolytic anemia, such as hereditary spherocytosis and autoimmune hemolytic anemia. (D) Increased bilirubin: Hemolysis leads to the breakdown of hemoglobin into heme and globin. Heme is further broken down into unconjugated bilirubin, resulting in hyperbilirubinemia. This can cause jaundice, a common clinical feature of hemolytic anemia.",
      "correct_choice_id": 257450,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24637681705130444/24637681705130444.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24637681705130444/24637681705130444.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76334,
      "choices": [
        {
          "id": 257454,
          "text": "Hemoglobinopathies"
        },
        {
          "id": 257455,
          "text": "Paroxysmal Nocturnal Hemoglobinuria"
        },
        {
          "id": 257456,
          "text": "Enzymopathies"
        },
        {
          "id": 257457,
          "text": "Membrane-cytoskeletal defects"
        }
      ],
      "text": "Which of the following haemolytic anemias occurs due to acquired intracorpuscular defect?",
      "unique_key": "Q1555152",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985820,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Paroxysmal Nocturnal Hemoglobinuria (PNH). Correct Response Explanation: Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired hemolytic anemia caused by an intracorpuscular defect. PNH occurs due to a somatic mutation in the PIGA gene in hematopoietic stem cells, leading to a deficiency of glycosylphosphatidylinositol (GPI)-anchored proteins. These proteins (e.g., CD55 and CD59) protect red blood cells from complement-mediated destruction. Without these, RBCs are vulnerable to intravascular hemolysis, especially during complement activation. Since this defect is acquired and occurs within the red blood cells themselves, it classifies as an acquired intracorpuscular defect. Incorrect Response Explanations: (A) Hemoglobinopathies: Hemoglobinopathies, such as sickle cell anemia and thalassemia, are caused by inherited genetic mutations in hemoglobin structure or production. These conditions are congenital intracorpuscular defects, not acquired. (C) Enzymopathies: Enzymopathies, like glucose-6-phosphate dehydrogenase (G6PD) deficiency, are inherited disorders of RBC enzymes. They lead to hemolysis but are also congenital intracorpuscular defects, not acquired. (D) Membrane-cytoskeletal defects: Membrane-cytoskeletal defects, such as hereditary spherocytosis or elliptocytosis, are caused by inherited mutations in RBC membrane proteins (e.g., spectrin, ankyrin). These are congenital, not acquired, defects.",
      "correct_choice_id": 257455,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25712351705130458/25712351705130458.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25712351705130458/25712351705130458.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76335,
      "choices": [
        {
          "id": 257458,
          "text": "Hereditary spherocytosis"
        },
        {
          "id": 257459,
          "text": "Paroxysmal Nocturnal Hemoglobinuria"
        },
        {
          "id": 257460,
          "text": "Sickle cell anaemia"
        },
        {
          "id": 257461,
          "text": "Thalassemia"
        }
      ],
      "text": "Below is the peripheral smear finding of a patient with a particular membrane cytoskeletal abnormality. What is the diagnosis ?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/239189Q.831.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2776956",
      "question_audio": null,
      "question_video": null,
      "map_id": 34034969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hereditary spherocytosis. Correct Response Explanation: Hereditary spherocytosis is a genetic disorder characterized by defects in the red blood cell (RBC) membrane, leading to the formation of spherocytes (spherical-shaped RBCs) rather than the typical biconcave shape. These abnormal RBCs are more prone to hemolysis, particularly in the spleen, due to their increased fragility. On a peripheral smear, the hallmark finding is spherocytes, which are small, round, and lack the central pallor seen in normal RBCs. This appearance is caused by defects in membrane proteins like spectrin, ankyrin, and band 3. Thus, the diagnosis is Hereditary spherocytosis, and the peripheral smear finding of spherocytes confirms this diagnosis. Incorrect Response Explanations: (B) Paroxysmal Nocturnal Hemoglobinuria (PNH): PNH is a condition where defective RBCs are prone to complement-mediated lysis, but the peripheral smear typically does not show spherocytes. Instead, PNH is characterized by the presence of polychromasia, anisocytosis, and fragmented red cells. The most significant feature is hemoglobinuria due to the lysis of RBCs. PNH may also show a lack of CD55 and CD59 on the RBC surface when analyzed by flow cytometry, but spherocytes are not a characteristic finding. (C) Sickle cell anemia: Sickle cell anemia is a hemoglobinopathy where the RBCs are deformed into a sickle shape, especially under low oxygen conditions. On a peripheral smear, sickle-shaped cells are seen, not spherocytes. Sickle cell anemia typically shows sickled cells, target cells, and howell-jolly bodies (due to splenic dysfunction), but it does not present with the spherocytes seen in hereditary spherocytosis. (D) Thalassemia: Thalassemia is a hemoglobinopathy characterized by defective hemoglobin synthesis, leading to microcytic, hypochromic RBCs. On a peripheral smear, the findings include target cells, basophilic stippling, and tear-drop shaped cells, but spherocytes are not typically seen. Thalassemia is also associated with iron overload and hemolysis, but the peripheral smear is different from that seen in hereditary spherocytosis.",
      "correct_choice_id": 257458,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55703541705130488/55703541705130488.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55703541705130488/55703541705130488.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76336,
      "choices": [
        {
          "id": 257462,
          "text": "Auer rod"
        },
        {
          "id": 257463,
          "text": "Bite cell"
        },
        {
          "id": 257464,
          "text": "Faggot cell"
        },
        {
          "id": 257465,
          "text": "Normoblast"
        }
      ],
      "text": "What is the arrow pointing to in the peripheral smear of this patient admitted for evaluation of anaemia ?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/course_file_meta/1310651Q.832.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4529923",
      "question_audio": null,
      "question_video": null,
      "map_id": 34225596,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Bite cell. Correct Response Explanation: Bite cells are a type of abnormal red blood cell that are typically seen in hemolytic anemia, especially in conditions like glucose-6-phosphate dehydrogenase (G6PD) deficiency. These cells are called bite cells because they appear to have a \"bite\" taken out of one side of the RBC, which is caused by the splenic macrophages removing parts of the damaged membrane of the RBC during the process of hemolysis. Bite cells are often observed in cases of oxidative stress, such as in G6PD deficiency, and are indicative of intravascular hemolysis. Incorrect Response Explanations: (A) Auer rod: Auer rods are needle-like inclusions seen in the cytoplasm of myeloblasts and are characteristic of acute myeloid leukemia (AML). Auer rods are not found in peripheral blood cells but are seen in the bone marrow of patients with AML. The image here does not show Auer rods, which are distinct from bite cells and typically seen in myeloid leukemias. (C) Faggot cell: Faggot cells are a type of abnormal myeloblast seen in acute promyelocytic leukemia (APL). These cells are characterized by bundles of Auer rods within their cytoplasm, which can give them a \"faggot\" appearance. Faggot cells are not related to peripheral blood changes seen in hemolytic anemia and are more specific to APL, which is a subtype of AML. (D) Normoblast: Normoblasts are immature red blood cells (also known as erythroblasts) that contain a nucleus. They are normally found in the bone marrow but are not typically seen in peripheral blood unless the bone marrow is under stress or there is extreme anemia or hemolysis. The image does not show a normoblast, as the cell with the arrow in the image does not have a nucleus, and normoblasts would generally appear with a nucleus that is extruded as they mature into erythrocytes.",
      "correct_choice_id": 257463,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1991381705130501/1991381705130501.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1991381705130501/1991381705130501.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76337,
      "choices": [
        {
          "id": 257466,
          "text": "March hemoglobinuria"
        },
        {
          "id": 257467,
          "text": "Paroxysmal Nocturnal Hemoglobinuria"
        },
        {
          "id": 257468,
          "text": "Paroxysmal Cold Hemoglobinuria"
        },
        {
          "id": 257469,
          "text": "All"
        }
      ],
      "text": "Intravascular hemolysis can occur in ?",
      "unique_key": "Q5810351",
      "question_audio": null,
      "question_video": null,
      "map_id": 34595255,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All. Correct Response Explanation: Intravascular hemolysis refers to the destruction of red blood cells within the blood vessels. It can occur due to several conditions that cause mechanical or immunologic damage to the red blood cells, leading to their rupture and the release of hemoglobin into the bloodstream. All the conditions listed (March hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria, Paroxysmal Cold Hemoglobinuria) are associated with intravascular hemolysis. Incorrect Response Explanations: (A) March hemoglobinuria: March hemoglobinuria occurs when physical exertion, especially in situations like long marches or running, causes trauma to red blood cells, resulting in their rupture and the release of hemoglobin into the urine. This is a form of intravascular hemolysis. The hemoglobin released in this condition can lead to hemoglobinuria, which is the presence of free hemoglobin in the urine. (B) Paroxysmal Nocturnal Hemoglobinuria (PNH): Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired disorder where red blood cells are more prone to complement-mediated destruction due to a defect in the glycosylphosphatidylinositol (GPI)-anchored proteins. This condition leads to intravascular hemolysis, which is often most apparent in the early morning due to acidification of urine overnight, causing hemoglobinuria and dark-colored urine. (C) Paroxysmal Cold Hemoglobinuria (PCH): Paroxysmal Cold Hemoglobinuria (PCH) is an autoimmune condition where cold-induced immune reactions lead to complement-mediated hemolysis. The Donath-Landsteiner antibody causes intravascular hemolysis when blood is exposed to colder temperatures, typically in the extremities, leading to hemoglobinuria upon rewarming. This condition also results in the destruction of red blood cells within the blood vessels, leading to intravascular hemolysis.",
      "correct_choice_id": 257469,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57969571705130515/57969571705130515.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57969571705130515/57969571705130515.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76338,
      "choices": [
        {
          "id": 257470,
          "text": "SLE"
        },
        {
          "id": 257471,
          "text": "CLL"
        },
        {
          "id": 257472,
          "text": "Inflammatory bowel disease"
        },
        {
          "id": 257473,
          "text": "All the above"
        }
      ],
      "text": "Warm autoimmune haemolytic anaemia can occur secondary to ?",
      "unique_key": "Q5607285",
      "question_audio": null,
      "question_video": null,
      "map_id": 34895102,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All the above. Correct Response Explanation: Warm autoimmune hemolytic anemia (AIHA) is a condition where the body's immune system produces antibodies that attack its own red blood cells, resulting in their premature destruction. This type of hemolytic anemia occurs most commonly due to the presence of IgG antibodies, which primarily react at body temperature (hence \"warm\"). Warm AIHA can occur secondary to a variety of conditions, including: Systemic lupus erythematosus (SLE): An autoimmune disorder that frequently involves the production of various autoantibodies, including those against red blood cells, leading to hemolysis. Chronic lymphocytic leukemia (CLL): A type of leukemia that often involves an immune system dysfunction, which may lead to the production of antibodies against red blood cells. Inflammatory bowel disease (IBD): Conditions like Crohn's disease and ulcerative colitis can also predispose individuals to autoimmune hemolytic anemia due to the chronic inflammation and immune system dysregulation. Incorrect Response Explanations: (A) SLE (Systemic Lupus Erythematosus): SLE is an autoimmune condition where the immune system attacks various tissues, including the red blood cells. It is one of the classic conditions that can lead to warm autoimmune hemolytic anemia, due to the production of autoantibodies (especially IgG antibodies). Therefore, it is correct that warm AIHA can occur secondary to SLE. (B) CLL (Chronic Lymphocytic Leukemia): Chronic lymphocytic leukemia (CLL) is a type of blood cancer that involves the proliferation of abnormal white blood cells. In CLL, immune dysregulation is common, and it can lead to the production of autoantibodies against red blood cells, causing warm AIHA. So, it is correct that warm AIHA can occur secondary to CLL. (C) Inflammatory Bowel Disease (IBD): Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, involves chronic inflammation of the gastrointestinal tract. This inflammation can trigger immune system abnormalities, including the production of autoantibodies against red blood cells, resulting in warm AIHA. Therefore, it is correct that warm AIHA can occur secondary to IBD.",
      "correct_choice_id": 257473,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49665341705130530/49665341705130530.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49665341705130530/49665341705130530.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76339,
      "choices": [
        {
          "id": 257474,
          "text": "Omalizumab"
        },
        {
          "id": 257475,
          "text": "Eculizumab"
        },
        {
          "id": 257476,
          "text": "Tofacitinib"
        },
        {
          "id": 257477,
          "text": "Bevacizumab"
        }
      ],
      "text": "Which monoclonal antibody is used in the treatment of paroxysmal nocturnal hemoglobinuria ?",
      "unique_key": "Q5835665",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127213,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Eculizumab. Correct Response Explanation: Eculizumab is a monoclonal antibody that is specifically used in the treatment of paroxysmal nocturnal hemoglobinuria (PNH). PNH is a rare hematological disorder characterized by hemolysis (destruction of red blood cells), thrombosis (blood clotting), and bone marrow failure due to a defect in the red blood cell membrane. The defect is caused by mutations in the PIGA gene, leading to the absence of certain complement-regulating proteins on the surface of red blood cells. Eculizumab works by inhibiting complement protein C5, preventing its cleavage into C5a and C5b. This inhibits the terminal complement cascade, which is responsible for the lysis of red blood cells in PNH. By blocking this pathway, eculizumab reduces hemolysis and associated complications, such as thrombosis. Incorrect Response Explanations: (A) Omalizumab: Omalizumab is a monoclonal antibody used primarily in the treatment of allergic asthma and chronic urticaria. It works by binding to IgE, the immunoglobulin responsible for allergic reactions, preventing it from attaching to mast cells and basophils. It is not used for the treatment of PNH. (C) Tofacitinib: Tofacitinib is a Janus kinase (JAK) inhibitor used in the treatment of rheumatoid arthritis and other autoimmune diseases. It works by inhibiting the JAK-STAT signaling pathway that affects immune cell function. It is not used to treat PNH. (D) Bevacizumab: Bevacizumab is a monoclonal antibody used in the treatment of various cancers. It works by inhibiting vascular endothelial growth factor (VEGF), which is involved in angiogenesis (formation of new blood vessels). It is not indicated for PNH treatment.",
      "correct_choice_id": 257475,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25278921705130545/25278921705130545.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25278921705130545/25278921705130545.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76340,
      "choices": [
        {
          "id": 257478,
          "text": "Kell"
        },
        {
          "id": 257479,
          "text": "P"
        },
        {
          "id": 257480,
          "text": "MNS"
        },
        {
          "id": 257481,
          "text": "ABO"
        }
      ],
      "text": "Antibodies to ……… blood group antigen causes Paroxysmal Cold Hemoglobinuria ?",
      "unique_key": "Q7837265",
      "question_audio": null,
      "question_video": null,
      "map_id": 34169992,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) P. Paroxysmal Cold Hemoglobinuria (PCH) is an autoimmune hemolytic anemia caused by the Donath-Landsteiner antibody, a type of IgG antibody. This antibody targets the P blood group antigen on red blood cells. In PCH, the Donath-Landsteiner antibody binds to red blood cells at cold temperatures (e.g., in peripheral circulation), activating the complement system and leading to hemolysis when the blood is warmed to body temperature. This biphasic hemolysis mechanism is characteristic of PCH, which is most commonly seen in children following viral infections or in adults with syphilis. A. Kell This option is incorrect because antibodies against the Kell antigen are associated with hemolytic disease of the newborn and transfusion reactions but are not involved in PCH. Unlike the Donath-Landsteiner antibody, anti-Kell antibodies do not cause cold-reactive hemolysis. C. MNS This option is incorrect because the MNS blood group system is associated with transfusion reactions and hemolytic disease of the newborn. While antibodies to M or N antigens can cause hemolysis, they do not exhibit the biphasic hemolysis characteristic of PCH. D. ABO This option is incorrect because antibodies to ABO antigens are naturally occurring IgM antibodies that cause acute hemolytic reactions during mismatched blood transfusions. They are not involved in PCH, which is mediated by the Donath-Landsteiner antibody targeting the P antigen.",
      "correct_choice_id": 257479,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43281131705131388/43281131705131388.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43281131705131388/43281131705131388.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76341,
      "choices": [
        {
          "id": 257482,
          "text": "Restart hydroxyurea"
        },
        {
          "id": 257483,
          "text": "Draw blood cultures and start antibiotics."
        },
        {
          "id": 257484,
          "text": "Surgery referral for gall bladder stone"
        },
        {
          "id": 257485,
          "text": "Obtain old records to confirm sickle cell disease in this patient."
        }
      ],
      "text": "A 28-year-old man with a history of sickle cell disease arrives at the emergency with recurrence of a pain crisis. He c/o pain in leg and chest. This is the same as his usual crisis. He has been noncompliant with hydroxyurea. Besides pain, he has had fever. Past medical h/o: Gallstones Osteomyelitis, Skin ulcers, Pneumonia and Priapism episode in past. On examination Respiratory rate: 28 breaths/minute; BP: 150/88 mm Hg; P: 120 beats/minute; T: 102 °F. What is the most important step at this time?",
      "unique_key": "Q6808988",
      "question_audio": null,
      "question_video": null,
      "map_id": 34137111,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Draw blood cultures and start antibiotics. This 28-year-old patient with sickle cell disease presents with a pain crisis, but he also has fever, which raises the concern for a possible infection. In sickle cell disease, patients are particularly vulnerable to infections due to splenic dysfunction, which impairs the body’s ability to clear encapsulated organisms, such as Streptococcus pneumoniae and Haemophilus influenzae. Fever in a patient with sickle cell disease should always be taken seriously, as it could indicate an underlying bacterial infection, such as pneumonia or osteomyelitis, both of which the patient has a history of. The immediate action is to draw blood cultures to identify the organism responsible for the infection, and start broad-spectrum antibiotics empirically while awaiting culture results. This is crucial to prevent the infection from progressing, as infections in sickle cell patients can quickly become life-threatening due to their compromised immune system. Incorrect Options: A. Restart hydroxyurea While hydroxyurea is an important medication for the long-term management of sickle cell disease, it is not an emergency intervention for the current symptoms, which are more acute and related to infection. The first priority in this patient is to address the acute fever and the potential underlying infection, rather than restarting a medication that is used for prevention of sickle cell crises. C. Surgery referral for gall bladder stone Although the patient has a history of gallstones, the acute presentation is more consistent with an infection (due to fever and the pain crisis) rather than gallbladder issues. Gallstones can cause symptoms such as biliary colic or cholecystitis, but these symptoms would not typically present with fever or the systemic signs of infection seen here. Therefore, a referral for gallbladder surgery is not the priority at this time. D. Obtain old records to confirm sickle cell disease in this patient The patient already has a known history of sickle cell disease, and there is no indication that confirmation of this diagnosis is necessary. The focus should be on managing the acute crisis and addressing the possible infection rather than revisiting the diagnosis.",
      "correct_choice_id": 257483,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70052891698817857/70052891698817857.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70052891698817857/70052891698817857.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76342,
      "choices": [
        {
          "id": 257486,
          "text": "Change antibiotics."
        },
        {
          "id": 257487,
          "text": "Provide continuous positive airway pressure."
        },
        {
          "id": 257488,
          "text": "Perform exchange transfusion."
        },
        {
          "id": 257489,
          "text": "Increase IV fluids"
        }
      ],
      "text": "A 30 year old male known case of sickle cell disease presented with chest pain, restlessness and dyspnea. He also c/o priapism. He is irregular with his prescribed medicines. He also c/o fever for 2 days. His oxygen saturation is 90%. Peripheral smear is done as shown in figure. You admit the patient. Despite giving oxygen, ceftriaxone and hydration, the patient’s chest pain and hypoxia worsen. What is the next step?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/11(199).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8305467",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197341,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Perform exchange transfusion. This patient, with sickle cell disease, is presenting with chest pain, dyspnea, restlessness, hypoxia, and fever, which are concerning for acute chest syndrome (ACS), a potentially life-threatening complication of sickle cell disease. ACS often presents with pain, hypoxia, and fever, and it can be precipitated by infection, fat embolism, or sickle cell-induced vaso-occlusion in the lungs. The worsening of symptoms despite oxygen therapy, antibiotics (ceftriaxone), and hydration indicates that the underlying sickling process has led to severe vaso-occlusion and hypoxia in the lungs. In sickle cell disease, the mainstay of treatment for severe acute chest syndrome is exchange transfusion, which reduces the percentage of sickled red blood cells in circulation, improves oxygenation, and relieves the vaso-occlusion. This intervention is necessary when symptoms worsen despite supportive therapy, as it addresses the root cause of the patient's condition. Incorrect Options: A. Change antibiotics Although the patient is presenting with symptoms of fever, indicating a possible infection, changing antibiotics is unlikely to significantly improve the current situation. The primary issue here is acute chest syndrome caused by sickle cell-induced vaso-occlusion and hypoxia, not necessarily an infection. Even though antibiotics may be required for treating potential pneumonia or bacterial infection, the immediate priority is to address the sickling crisis with exchange transfusion, which directly impacts the pathophysiology of the condition. B. Provide continuous positive airway pressure (CPAP) While CPAP may be useful in certain cases of respiratory distress or hypoxia, it does not address the underlying cause of the patient's symptoms, which is sickle cell-induced vaso-occlusion in the lungs. In the case of acute chest syndrome, exchange transfusion is a much more effective intervention in reducing sickling and improving oxygenation. CPAP may be considered as an adjunct, but it is not the most appropriate first-line treatment in this case. D. Increase IV fluids While hydration is an important part of sickle cell management, increasing IV fluids alone is unlikely to significantly improve the patient's condition in this setting, especially when symptoms are worsening despite hydration. The acute chest syndrome is primarily driven by vaso-occlusion and sickling of red blood cells in the lungs, which requires exchange transfusion to decrease the sickle cell burden and improve oxygenation. Increasing fluids may help with overall circulation, but it is not sufficient to manage the acute chest syndrome in this patient.",
      "correct_choice_id": 257488,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1084291698817912/1084291698817912.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1084291698817912/1084291698817912.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76343,
      "choices": [
        {
          "id": 257490,
          "text": "Hereditary spherocytosis"
        },
        {
          "id": 257491,
          "text": "Malaria"
        },
        {
          "id": 257492,
          "text": "Viral Hepatitis"
        },
        {
          "id": 257493,
          "text": "Autoimmune hemolytic anemia"
        }
      ],
      "text": "A 43-year-old woman recently treated for a dental abscess with amoxicillin presents to the emergency department with 2 days of progressively worsening weakness, fatigue, and yellow skin. She says that her friends told her that her eyes have turned yellow. On examination respiratory rate: 22 breaths/minute; BP: 100/60 mm Hg; P: 120 beats/minute; icterus +, Abdomen: soft, nontender, no spleen felt. Laboratory Test Results: LFTs: normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT); total bilirubin 8 mg/dL, direct bilirubin 0.8 mg/dL.CBC: Hb-6.0%, Haptoglobin: decreased, Reticulocyte count: 8%,Coombs test: positive IgG warm antibody,Peripheral Smear: no schistocytes; no fragmented cells; spherocytes are seen.What is likely cause of her presentation?",
      "unique_key": "Q6611865",
      "question_audio": null,
      "question_video": null,
      "map_id": 34745346,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Autoimmune hemolytic anemia. This patient presents with yellowing of the skin (icterus), weakness, and fatigue, along with anemia (Hb 6.0%) and elevated total bilirubin (8 mg/dL), which suggests hemolysis. The presence of spherocytes on the peripheral smear and a positive Coombs test (for IgG warm antibodies) are strong indicators of autoimmune hemolytic anemia (AIHA). AIHA occurs when the body's immune system mistakenly produces antibodies against its own red blood cells, leading to their premature destruction in the spleen. This often results in hemolysis, anemia, and jaundice. The warm antibody type of AIHA is most commonly associated with drugs, infections, or autoimmune diseases. In this case, the patient was recently treated with amoxicillin, which can trigger drug-induced AIHA, particularly through the formation of antibodies that target red blood cells. The low haptoglobin and high reticulocyte count further support ongoing hemolysis. Incorrect Options: A. Hereditary spherocytosis While hereditary spherocytosis can also lead to spherocytes on peripheral smear, it is a genetic disorder characterized by a defect in the red blood cell membrane, leading to the premature destruction of red blood cells in the spleen. However, this patient's recent dental abscess treatment with amoxicillin and the positive Coombs test are more suggestive of autoimmune hemolytic anemia. Hereditary spherocytosis would not cause a positive Coombs test, as this test specifically detects antibodies against red blood cells, which is not a feature of hereditary spherocytosis. B. Malaria Malaria can lead to hemolysis and jaundice, but this patient's presentation is more consistent with autoimmune hemolytic anemia, given the positive Coombs test and the recent use of amoxicillin. Malaria typically presents with symptoms such as fever, chills, and splenomegaly, which are not mentioned in this case. The peripheral smear in malaria typically shows plasmodium parasites inside red blood cells, which is not seen here. C. Viral Hepatitis Viral hepatitis can cause jaundice due to liver dysfunction, but it would not cause anemia or spherocytes on the peripheral smear. Additionally, this patient’s LFTs are reported as normal (normal AST and ALT), which argues against viral hepatitis as the primary cause of her presentation. The positive Coombs test and spherocytes are more indicative of autoimmune hemolytic anemia, not liver disease.",
      "correct_choice_id": 257493,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58883331698817961/58883331698817961.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58883331698817961/58883331698817961.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76344,
      "choices": [
        {
          "id": 257494,
          "text": "Splenectomy"
        },
        {
          "id": 257495,
          "text": "Start IVIG."
        },
        {
          "id": 257496,
          "text": "Add dexamethasone to methylprednisolone."
        },
        {
          "id": 257497,
          "text": "Perform plasmapheresis."
        }
      ],
      "text": "A 40 year old male patient presented with anemia preceded by intake of ampicillin for sore throat. Lab investigations revealed- Hb:6.5%, reticulocyte count 4%,and coombs test positive.A diagnosis of drug induced autoimmune hemolytic anemia is made. Methylprednisolone and folic acid are started. After transfusion of two units of packed RBCs is given hb remains low. What should you do to increase the hb?",
      "unique_key": "Q8358200",
      "question_audio": null,
      "question_video": null,
      "map_id": 34974286,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Start IVIG (Intravenous Immunoglobulin). In cases of drug-induced autoimmune hemolytic anemia, the Coombs test is typically positive, indicating the presence of antibodies against the red blood cells. Although the patient has been started on methylprednisolone (a corticosteroid) and folic acid, anemia persists despite transfusion, suggesting ongoing hemolysis. In such situations, the next step is often intravenous immunoglobulin (IVIG). IVIG is used to reduce the immune-mediated destruction of red blood cells by inhibiting the function of the antibodies. This treatment can be very effective in drug-induced hemolytic anemia, particularly when corticosteroids alone do not lead to sufficient improvement. IVIG helps to block the Fc receptors on macrophages in the spleen, thereby reducing the splenic destruction of red blood cells. Incorrect Options: A. Splenectomy Splenectomy is sometimes considered for immune-mediated hemolytic anemia when other treatments fail, particularly for primary autoimmune hemolytic anemia. However, in the context of drug-induced autoimmune hemolytic anemia, the cause of hemolysis is related to drug exposure and the body's immune response to it. Splenectomy would not be the most appropriate first-line approach in this case, especially when IVIG or other immunomodulatory therapies are more likely to control the hemolysis and improve hemoglobin levels. C. Add dexamethasone to methylprednisolone Corticosteroids, like methylprednisolone, are a common treatment for autoimmune hemolytic anemia, but adding dexamethasone is not typically necessary unless there is inadequate response. If the patient is not responding to methylprednisolone, other therapies, like IVIG, should be considered before escalating the corticosteroid dose. Adding another corticosteroid like dexamethasone is unlikely to offer significant additional benefit in this case. D. Perform plasmapheresis Plasmapheresis is generally used in severe cases of autoimmune hemolytic anemia where other treatments fail, particularly for conditions like severe autoimmune hemolytic anemia or myasthenia gravis. However, it is not the first-line treatment for drug-induced hemolytic anemia. The treatment of choice for drug-induced cases usually involves IVIG or corticosteroids, and plasmapheresis would not typically be indicated unless the patient is refractory to these treatments.",
      "correct_choice_id": 257495,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73975691698817986/73975691698817986.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73975691698817986/73975691698817986.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76345,
      "choices": [
        {
          "id": 257498,
          "text": "Autoimmune hemolytic anemia"
        },
        {
          "id": 257499,
          "text": "PNH"
        },
        {
          "id": 257500,
          "text": "Hereditary spherocytosis"
        },
        {
          "id": 257501,
          "text": "G6PD deficiency"
        }
      ],
      "text": "A 23-year-old man comes to the emergency department with complaints of a few hours of dark urine and fatigue. He had been having a cough with sputum and fever for the past 2 days. His condition suddenly got worse after his temperature went up early today. He has not started any new medications recently. On examination- respiratory rate: 25 breaths/minute; BP: 110/70 mm Hg; P: 105 beats/minute; Temperature: 101°F.Chest: rales at right base, Abdomen: nontender liver Neurological: normal, icterus +. Laboratory Test Results: CBC:Hb-8.0%, ; MCV 90 fL; WBC and platelet counts normal, coomb’s test is negative. Chest x-ray: right lower lobe infiltrate LFTs: total bilirubin 6.8 mg/dL; direct bilirubin1.2 mg/dL; LDH elevated, AST and ALT normal, Urine Analysis: dipstick positive for blood, but no RBCs seen, Oximeter: 92% on room air.What is the most likely cause of this anemia",
      "unique_key": "Q3642553",
      "question_audio": null,
      "question_video": null,
      "map_id": 34896164,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) PNH (Paroxysmal Nocturnal Hemoglobinuria). This patient presents with dark urine, fatigue, and jaundice (icterus), along with laboratory findings of elevated LDH, normal liver enzymes (AST/ALT), and a negative Coombs test. The absence of RBCs on urine microscopy but the presence of blood on dipstick suggests hemoglobinuria, which is a key feature of hemolysis occurring in PNH. PNH is a rare, acquired hemolytic anemia caused by a defect in the PIGA gene, leading to the absence of glycosylphosphatidylinositol (GPI)-anchored proteins on red blood cells. This results in complement-mediated hemolysis, especially during periods of increased complement activation, such as infections (as seen in this case, where the patient has a recent respiratory infection). The hemoglobinuria is most commonly seen in the morning (hence the term \"nocturnal\"), though it can occur at any time if hemolysis is significant. The patient’s symptoms of fever, cough, and right lower lobe infiltrate could also indicate an infection, which can trigger hemolysis in PNH patients. Additionally, elevated LDH and bilirubin are markers of hemolysis, supporting this diagnosis. Incorrect Options: A. Autoimmune hemolytic anemia (AIHA) In AIHA, the Coombs test would typically be positive, indicating the presence of antibodies on the surface of red blood cells. However, this patient's Coombs test is negative, which rules out autoimmune hemolytic anemia as the cause of his hemolysis. Moreover, AIHA does not typically present with dark urine or hemoglobinuria in the absence of RBCs on urine microscopy. C. Hereditary spherocytosis Hereditary spherocytosis is characterized by spherocytes (abnormally shaped red blood cells) on the peripheral smear, typically associated with splenomegaly and chronic hemolysis. The patient does not exhibit splenomegaly, and the peripheral smear was not described to show spherocytes. Furthermore, dark urine and hemoglobinuria are more characteristic of PNH rather than hereditary spherocytosis. D. G6PD deficiency G6PD deficiency usually leads to hemolytic anemia triggered by oxidative stress, such as infection, medications, or fava beans. While infection could be a potential trigger, the patient has no recent medication use or known triggers for G6PD deficiency. Furthermore, the absence of bite cells or Heinz bodies on the peripheral smear further supports that this is not G6PD deficiency. Additionally, the Coombs test is negative, which rules out autoimmune hemolysis that could occur in the context of G6PD deficiency.",
      "correct_choice_id": 257499,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35066191698817998/35066191698817998.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35066191698817998/35066191698817998.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76346,
      "choices": [
        {
          "id": 257502,
          "text": "G6PD level"
        },
        {
          "id": 257503,
          "text": "Complement levels"
        },
        {
          "id": 257504,
          "text": "Brilliant cresyl blue stain for Heinz bodies"
        },
        {
          "id": 257505,
          "text": "Genetic studies"
        }
      ],
      "text": "A 20 year old male was diagnosed as having malaria and was given primaquine. On third of primaquine patient c/o fatique, weakness and dyspnea. Physical examination-icterus +,abdomen, respiratory system and cardiovascular system are normal. Lab results showed-Hb 9.0%,reticulocyte count 4%,high indirect bilirubin. You are suspecting G6PD deficiency. Which of the following should be tested first to find G6PD deficiency?",
      "unique_key": "Q7385107",
      "question_audio": null,
      "question_video": null,
      "map_id": 34178406,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Brilliant cresyl blue stain for Heinz bodies. In this case, the patient is presenting with fatigue, weakness, and dyspnea after receiving primaquine for malaria. This is highly suggestive of hemolysis induced by oxidative stress, which can occur in patients with G6PD deficiency when exposed to oxidative drugs like primaquine. One of the key findings in G6PD deficiency hemolysis is the formation of Heinz bodies—precipitated hemoglobin molecules caused by oxidative damage to red blood cells. To confirm this, Brilliant cresyl blue stain is used to detect the presence of Heinz bodies in the red blood cells. This test is a quick, direct method for identifying the acute hemolysis triggered by G6PD deficiency. Incorrect Options: A. G6PD level While measuring the G6PD level would ultimately confirm the diagnosis of G6PD deficiency, this test is not ideal during an acute hemolytic episode. In the context of acute hemolysis, the G6PD levels may appear normal or falsely elevated because the older red blood cells (which are deficient in G6PD) have already been destroyed. Therefore, performing a G6PD level test immediately after an episode of hemolysis could give misleading results. It is better to perform the test a few weeks later, when the newer red blood cells, which have normal enzyme activity, are present. B. Complement levels Complement levels are generally tested to evaluate conditions involving immune-mediated hemolysis or autoimmune disorders, such as paroxysmal nocturnal hemoglobinuria (PNH) or autoimmune hemolytic anemia. In this case, the patient's presentation is most likely due to G6PD deficiency rather than a complement-related hemolytic process, so measuring complement levels is not indicated for diagnosing G6PD deficiency. D. Genetic studies Genetic testing for G6PD deficiency would provide a definitive diagnosis, but it is not necessary to confirm the diagnosis in the acute setting. Genetic studies can be useful for confirming the diagnosis of G6PD deficiency once it is suspected, but they are not the immediate next step in the management of this patient. Heinz body formation and the clinical signs of hemolysis are more relevant at this stage.",
      "correct_choice_id": 257504,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48617261698818015/48617261698818015.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48617261698818015/48617261698818015.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76347,
      "choices": [
        {
          "id": 257506,
          "text": "Continue Supportive therapy"
        },
        {
          "id": 257507,
          "text": "Steroids"
        },
        {
          "id": 257508,
          "text": "Intravenous G6PD"
        },
        {
          "id": 257509,
          "text": "IVIGs"
        }
      ],
      "text": "Patient presented to emergency and diagnosed as a case of G6PD deficiency induced hemolysis after taking antibiotics for urinary tract infection. Supportive treatment with IV fluids was started. He insisted on getting the CBC done again to see improvement. The follow-up CBC the next day shows no significant change in Hb and hematocrit. What is the treatment?",
      "unique_key": "Q4870145",
      "question_audio": null,
      "question_video": null,
      "map_id": 34062721,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Continue Supportive therapy. In the case of G6PD deficiency-induced hemolysis, the primary treatment is supportive care, which includes hydration and monitoring for complications such as acute renal failure. The hemolysis in this condition is usually self-limiting once the offending trigger (such as the antibiotics) is discontinued. The Hb and hematocrit levels may remain low for some time after hemolysis starts, but this does not necessarily mean that the patient's condition is worsening. The body compensates for the destruction of red blood cells by increasing the production of new red blood cells, and over time, the hemolysis should resolve. Therefore, supportive therapy with IV fluids and close monitoring is appropriate in this case, with no immediate need for more aggressive interventions. Incorrect Options: B. Steroids Steroids are typically used in conditions involving immune-mediated hemolysis, such as autoimmune hemolytic anemia or immune-related hemolytic episodes, but they are not effective in the treatment of G6PD deficiency-induced hemolysis. This condition is a result of oxidative stress on red blood cells, not immune destruction, so steroids are not indicated. The condition resolves once the oxidative stress is removed (i.e., when the offending drug is stopped). C. Intravenous G6PD There is no available intravenous G6PD enzyme replacement for treating G6PD deficiency. The treatment for G6PD deficiency is supportive and involves avoiding triggers of hemolysis. Giving G6PD enzyme intravenously is not a recognized therapy for this condition, and therefore this option is not appropriate. D. IVIGs Intravenous immunoglobulins (IVIGs) are used in conditions involving immune-mediated hemolysis or autoimmune hemolytic anemia, where the body's immune system mistakenly attacks its red blood cells. However, in G6PD deficiency-induced hemolysis, the problem is oxidative stress, not an immune attack on red blood cells. Therefore, IVIGs would not be effective and are not indicated in this scenario.",
      "correct_choice_id": 257506,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26900941698818051/26900941698818051.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26900941698818051/26900941698818051.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76348,
      "choices": [
        {
          "id": 257510,
          "text": "Paroxysmal Nocturnal hemoglobinuria"
        },
        {
          "id": 257511,
          "text": "Autoimmune hemolytic anemia"
        },
        {
          "id": 257512,
          "text": "G6PD deficiency"
        },
        {
          "id": 257513,
          "text": "Hereditary spherocytosis"
        }
      ],
      "text": "A 24-year-old man with intermittent episodes of dark urine in the morning comes to your OPD. He has been feeling weak and tired for months. He gets short of breath when he is walking up stairs and is easily fatigued. He does not have a fever and has not had any infections in the past. Past medical history: thrombosis of portal vein 2 years ago treated with 6 months of warfarin Present Medications: none, On examination Respiratory rate: 16 breaths/minute; BP: 120/80 mm Hg; P: 70 beats/minutes; T: 98°F. Pallor +,icterus +,CVS, respiratory system and Neurological: normal findings. Reports: CBC:Hb-8.9 g/dl, WBCs 2,900/μL (low); platelets 80,000/μL (low), Urine Analysis: dipstick positive for hemoglobin ,Serum potassium 5.5 mEq /L;serum indirect bilirubin 4.2 mg/dL (elevated); LDH elevated. Smear: schistocytes, fragmented cells,Reticulocytes: 14%, Haptoglobin: decreased Coombs test: negative.What is the likely cause of this presentation",
      "unique_key": "Q4249787",
      "question_audio": null,
      "question_video": null,
      "map_id": 34515117,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Paroxysmal Nocturnal Hemoglobinuria (PNH). The patient's presentation strongly suggests Paroxysmal Nocturnal Hemoglobinuria (PNH), which is characterized by episodic hemoglobinuria (dark urine, especially in the morning), pallor, icterus, and evidence of hemolysis. The schistocytes on the peripheral smear, decreased haptoglobin, and elevated LDH point to hemolytic anemia, which is commonly seen in PNH. PNH is caused by an acquired defect in the phosphatidylinositol glycan class A (PIGA) gene, leading to the loss of GPI-anchored proteins on red blood cells, which renders them susceptible to complement-mediated lysis. This results in episodes of hemoglobinuria, especially after overnight hemolysis (hence \"nocturnal\"). The low white blood cell and platelet counts can also be seen in PNH, due to the effect of the disease on hematopoietic stem cells. Incorrect Options: B. Autoimmune hemolytic anemia (AIHA) While AIHA can cause hemolytic anemia, the key findings here—such as the absence of schistocytes (which are present in PNH), the negative Coombs test, and the specific pattern of hemoglobinuria—do not support this diagnosis. AIHA is typically characterized by positive Coombs test (which detects antibodies or complement on the red blood cells), whereas this patient's Coombs test is negative. Also, AIHA does not typically present with the episodic dark urine seen in PNH, and the hemolysis in AIHA is usually not as episodic or associated with nocturnal hemoglobinuria. C. G6PD deficiency G6PD deficiency can cause hemolysis, especially after exposure to oxidative stress (e.g., infections or certain medications), but it typically presents with acute hemolytic episodes triggered by specific factors such as infections, drugs, or fava beans. In this case, the patient's intermittent episodes of dark urine without a clear triggering factor (like an infection or exposure to drugs) and the presence of schistocytes make G6PD deficiency less likely. Additionally, G6PD deficiency often has a history of exposure to oxidant stress, which this patient does not report. D. Hereditary spherocytosis Hereditary spherocytosis is a hemolytic anemia due to defects in the red blood cell membrane, leading to spherocytes in the peripheral blood smear. However, hereditary spherocytosis typically does not present with dark urine or schistocytes, which are more characteristic of microangiopathic hemolysis, as seen in PNH. Additionally, the negative Coombs test and the absence of family history or history of splenomegaly (common in hereditary spherocytosis) further point away from this diagnosis.",
      "correct_choice_id": 257510,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30868291698818070/30868291698818070.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30868291698818070/30868291698818070.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76349,
      "choices": [
        {
          "id": 257514,
          "text": "Sugar water (sucrose hemolysis) test"
        },
        {
          "id": 257515,
          "text": "CD55 and CD59 by flow cytometry"
        },
        {
          "id": 257516,
          "text": "Ham test"
        },
        {
          "id": 257517,
          "text": "Complement levels"
        }
      ],
      "text": "A 20 year old male presented with c/o dark urine in early morning with clearing in day time. He has h/o pulmonary embolism due to renal vein thrombosis 2 years back. Lab results shows- Hb 6.7%,undetectable serum haptoglobin, low WBC, low platelets. What is the most accurate test to establish a diagnosis of the patient disease process?",
      "unique_key": "Q9687838",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684300,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) The clinical presentation is suggestive of Paroxysmal Nocturnal Hemoglobinuria. CD55 and CD59 are the markers for complement-removing proteins indicating the deficiency of glycosylphosphatidylinositol (GPI), a protein that characterizes PNH. Normally, complement attaches to cells, but is removed by certain proteins before they are able to destroy the RBC. These proteins act as complement-removing factors and are sometimes called decay-accelerating factors. They anchor to the RBC on GPI. PNH is a genetic defect in GPI. The complement-removing proteins do not attach. Cells are then destroyed by complement. Clinical pearls The mutation-damaging GPI is on the stem cell. PNH Stem Cell Defect leads to Pancytopenia. PNH can transform into acute leukemia,Aplastic anemia and myelodysplasia The only way to cure PNH is bone marrow transplant to remove the underlying stem cell defect.",
      "correct_choice_id": 257515,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59339211698818091/59339211698818091.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59339211698818091/59339211698818091.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76350,
      "choices": [
        {
          "id": 257518,
          "text": "Supportive treatment and observe."
        },
        {
          "id": 257519,
          "text": "Start ciprofloxacin."
        },
        {
          "id": 257520,
          "text": "Give platelet transfusion"
        },
        {
          "id": 257521,
          "text": "IV steroids"
        }
      ],
      "text": "A 13-year-old boy with a recent diarrheal episode for 5 days presented to emergency department by parents with complaint of dark urine and fatigue developed over the last day. He has been febrile. There is some blood in the stool. His skin has been yellow. BP: 90/50 mm Hg; Pulse: 122 beats/minute; T: 101°F. Abdomen: mild diffuse tenderness, Chest: clear, Neurological: normal examination: serum creatinine 1.9 mg/dL, CBC:hb-7.0 g/dl; platelets 38,000/μL UA: hemoglobin present; no bilirubin. Chest x-ray: normal Liver: serum total bilirubin 5 mg/dL, indirect bilirubin 4 mg/dl; LDH elevated. What is the most appropriate next step for this patient?",
      "unique_key": "Q1757812",
      "question_audio": null,
      "question_video": null,
      "map_id": 34757229,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Supportive treatment and observe. This 13-year-old patient is presenting with hemolytic anemia (indicated by dark urine, fatigue, low hemoglobin, elevated LDH, and decreased haptoglobin) following a recent diarrheal illness with blood in stool and fever. Given the elevated LDH, total bilirubin, and indirect bilirubin, along with the mild diffuse abdominal tenderness, it suggests a diagnosis of hemolytic uremic syndrome (HUS), which is commonly triggered by Shiga toxin-producing Escherichia coli (STEC) infection, particularly from E. coli O157:H7. HUS typically presents with microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). The appropriate first-line management for HUS is supportive care with close monitoring of kidney function and electrolytes. In severe cases, additional treatments like plasma exchange may be considered, but the patient in this case is in the early stages of HUS, and supportive care is the most appropriate next step. This includes hydration, electrolyte correction, and monitoring renal function. Incorrect Options: B. Start ciprofloxacin While Shiga toxin-producing Escherichia coli (STEC) is typically the cause of HUS, antibiotics like ciprofloxacin are generally not recommended in the treatment of STEC infections. Antibiotics can increase the risk of HUS by promoting the release of Shiga toxin. Therefore, starting antibiotics is not advisable in this case. C. Give platelet transfusion Platelet transfusions are not indicated in HUS unless there is severe bleeding or life-threatening hemorrhage. In this patient, the thrombocytopenia (platelet count of 38,000/µL) is a result of hemolysis and is part of the HUS pathology, but transfusion of platelets is generally avoided because it can potentially exacerbate thrombotic complications. Platelet transfusion should only be considered in the case of significant bleeding. D. IV steroids IV steroids are used in autoimmune-related hemolytic anemias or certain inflammatory conditions, but they are not indicated in HUS, which is caused by a bacterial toxin. In HUS, supportive care is the primary treatment, and the use of steroids is not recommended as it does not address the underlying cause of the disease and can lead to unnecessary side effects.",
      "correct_choice_id": 257518,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68097371698818117/68097371698818117.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68097371698818117/68097371698818117.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76351,
      "choices": [
        {
          "id": 257522,
          "text": "IV steroids"
        },
        {
          "id": 257523,
          "text": "Antibiotics"
        },
        {
          "id": 257524,
          "text": "Platelet transfusion"
        },
        {
          "id": 257525,
          "text": "Plasmapheresis"
        }
      ],
      "text": "A 40 year old male presented with 3 days history of fever, decreased urine output and confusion. On examination facial puffiness is present, CNS-patient disoriented but no focal neurological deficit, no neck rigidity. Laboratory test results:Hb-8.8%,reticulocyte count 5%,:creatinine 2.4 mg/dL CBC: Hb- 8.4 g/dl, platelets 34,000/μL. Peripheral smear done is shown in the figure. Coombs test is negative, aPPT-normal. What will be most appropriate line of treatment<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/20(115).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9430046",
      "question_audio": null,
      "question_video": null,
      "map_id": 34800968,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Plasmapheresis. This 40-year-old male is presenting with fever, decreased urine output, confusion, facial puffiness, and thrombocytopenia. His peripheral smear shows schistocytes, suggesting microangiopathic hemolytic anemia (MAHA). The patient's creatinine is elevated, and he is showing signs of acute kidney injury (AKI). These findings are highly suggestive of Thrombotic Thrombocytopenic Purpura (TTP), a condition characterized by MAHA, thrombocytopenia, renal impairment, and neurological symptoms. TTP is caused by a deficiency in ADAMTS13, an enzyme that cleaves von Willebrand factor, leading to the formation of platelet-rich thrombi and causing microvascular occlusion. The first-line treatment for TTP is plasmapheresis (also known as plasma exchange), which helps to replace the deficient ADAMTS13 enzyme and remove the circulating autoantibodies that are inhibiting it. Plasmapheresis is crucial in managing TTP and can significantly improve the patient's condition by reversing the microthrombi formation and addressing the underlying process. Incorrect Options: A. IV steroids IV steroids are commonly used in autoimmune-related hemolytic anemias, but they are not effective in TTP. The pathogenesis of TTP is related to a deficiency in ADAMTS13, and steroids do not address this issue. In TTP, plasmapheresis is the mainstay of treatment, while steroids may be used as adjunct therapy in some cases but are not first-line treatment. B. Antibiotics Although this patient presents with fever, there is no clear evidence of an infection. His presentation, including the microangiopathic hemolytic anemia, thrombocytopenia, and renal dysfunction, is more consistent with a hematological disorder like TTP rather than a bacterial infection. Antibiotics would not be helpful in managing this patient's condition, and empirical antibiotic use should be avoided unless there is evidence of infection. C. Platelet transfusion Platelet transfusion is generally contraindicated in TTP because it can exacerbate the formation of microthrombi and worsen the patient's condition. TTP is not a disorder of platelet depletion but rather of platelet aggregation in microvessels, so transfusing platelets could lead to more thrombosis. The treatment for TTP focuses on addressing the underlying pathophysiology through plasmapheresis.",
      "correct_choice_id": 257525,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11317341705127779/11317341705127779.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11317341705127779/11317341705127779.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}